Maria Rojeski

Receptors for Insulin-like Growth Factors I and II: Autoradiographic Localization in Rat Brain and Comparison to Receptors for Insulin*

Maxine A. Lesniak, Joanna M. Hill, Maria Rojeski et al. · Endocrinology · 1988 · 252 citations

Medicine, Endocrinology, Neurobiology +8

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Philip Home, Richard M. Bergenstal, Geremia B. Bolli et al. · Diabetes Care · 2015 · 222 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Felicia Cosman, David L. Kendler, Bente Langdahl et al. · Osteoporosis International · 2022 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Insulin-Like Growth Factor-II in Nonislet Cell Tumors Associated with Hypoglycemia: Increased Levels of Messenger Ribonucleic Acid*

William L. Lowe, Charles T. Roberts, Derek LeRoith et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 57 citations

Medicine, Cancer Biology, Oncology +5

<i>T</i>-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial

Felicia Cosman, E. Michael Lewiecki, Peter R. Ebeling et al. · Journal of Bone and Mineral Research · 2020 · 53 citations · Full text

Medicine, Orthopedic Surgery, Bone Grafting +16